This news is delayed by 15 minutes, sign up now to get live news & full features.
NRSN NEUROSENSE THERAPEUTICS LTD
+ add to watchlist
$1.30
advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa
Mkt Cap: $17.33M
52 Week High: $2.60
P/E: 0.00
52 Week Low: $0.80
Dividend: $0.00
Shares Outstanding: